Tenax Therapeutics Stock Price - TENX

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Tenax Therapeutics Inc TENX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.0024 -0.42% 0.5667 0.57 0.64 0.59 0.569101 00:00:01
Bid Price Ask Price Spread Spread % News
0.3222 0.69 0.3678 53.3% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
630 179,520 $ 0.5922533 $ 106,321 106,644 0.25 - 2.70
Last Trade Time Type Quantity Stock Price Currency
16:00:00 1,002 $ 0.5667 USD

Tenax Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.89M 6.86M $ -6.81M -9.03 - 5.24M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Tenax Therapeutics News

Loading Messages....

Latest TENX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TENX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.520.680.450.5362772266,5570.04678.98%
1 Month1.,968-0.6033-51.56%
3 Months1.371.560.250.8847781,021-0.8033-58.64%
6 Months1.201.740.250.995555556,350-0.6333-52.78%
1 Year1.802.700.251.72158,854-1.23-68.52%
3 Years9.9015.800.255.23335,436-9.33-94.28%
5 Years63.6079.600.2511.60297,748-63.03-99.11%

Tenax Therapeutics Description

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market. The company develops novel product candidates such as Levodimendan IV that have the potential to address various critical care conditions with a high unmet medical need. Its drugs help in the reduction of morbidity and mortality in cardiac surgery patients. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure.

Your Recent History
Tenax Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.